Organisation
Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE)
Division
- Lung and chest wall mechanics: respiratory function in health and disease and effects of drugs. - Lung toxicology: fundamental mechanisms and epidemiologic research on occupational hazards. - Biochemical and metabolic functions of lung in health and disease and animal models. - Bronchial carcinoma: PET-scan, therapeutic modalities. - Respiratory muscles: animal models and changes in disease. - Difficult asthma. - Pulmonary embolism and hypertension. - COPD and rehabilitation.
Current researchers
31 - 40 of 60 results
- Janne Kaes (Member)
- Pieterjan Kerckhof (Member)
- Phéline Kortleven (Member)
- Natalie Lorent (Member)
- Karen Maes (Member)
- Nora Marain (Member)
- Marina Monteiro Carvalho Mori Da (Member)
- Johnny Moons (Member)
- Kristiaan Nackaerts (Member)
- Philippe Nafteux (Member)
Projects
31 - 40 of 185
- Data driven approaches for personalised medicineFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Effects of ambient air pollution on angiogenesis driving chronic thromboembolic pulmonary hypertensionFrom26 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A Tumor Immune Micro Environment (TIME)-on-chip: an in vitro model for immuno-oncology and immunotherapy screeningFrom23 Sep 2022 → TodayFunding: FWO fellowships
- Preclinical evaluation of decellularized abdominal muscles to repair complex abdominal wall defectsFrom1 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Co-designing a Core Outcome Set for and with patients with Idiopathic Pulmonary Fibrosis (COCOS-IPF)From1 Jun 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Computational fluid dynamics (CFD) analysis of small airways in the human lungFrom22 Mar 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Transcriptome-based management and therapeutic intervention of chronic lung allograft dysfunction.From1 Feb 2022 → 31 Jan 2024Funding: Foreign private sponsor - undefined
- Breath Analysis In Esophageal Cancer: The evolution towards minimally invasive patient-tailored diagnosticsFrom25 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Transcriptome-based management of transplant-related pulmonary fibrosis in chronic pulmonary rejection after lung or allogeneic stem cell transplantationFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 3082
- SUPERIOR LUNG FUNCTION WITH ONCE-DAILY QVA149 TRANSLATES INTO IMPROVEMENTS IN PATIENT-REPORTED BREATHLESSNESS COMPARED WITH PLACEBO AND TIOTROPIUM IN COPD PATIENTS: THE BLAZE STUDY(2013)
Authors: A D'Urzo, DA Mahler, Marc Decramer, H Worth, T White, VKT Alagappan, N Gallagher, H Chen, K Kulich, D Banerji
Pages: A184 - A184 - Preoperative chemotherapy plus surgery versus surgery alone in early-stage non-small cell lung cancer(2010)
Authors: S Derijcke, Johan Vansteenkiste
Pages: 196 - 197 - Cytospin Preparations Provide Better Quality Diagnoses Than Direct Smears in Nodal Needle Aspiration Specimens For Non-Small Cell Carcinoma (NSCLC): A Multicentre Review(2010)
Authors: C Rowan, K Tournoy, Christophe Dooms, R Rintoul, J Annema, P Shah, D Rassl, A Nicholson
Pages: S24 - S24 - Capmatinib in patients with METex14-mutated advanced non-small cell lung cancer who received prior immunotherapy: The phase II GEOMETRY mono-1 study(2020)
Authors: Johan Vansteenkiste, EF Smit, HJM Groen, EB Garon, RS Heist, T Hida, M Nishio, K Kokowski, C Grohe, N Reguart, et al.
Pages: S830 - S830 - Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension(2019)
Authors: Pedro Ferreira
Pages: 932 - 948 - Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2(2016)
Authors: J Granton, E Bergot, A Boonstra, PE Subias, N Galie, D Langleben, JC Lemarie, T Pfister, G Simonnau, O Sitbon, et al.
Pages: S358 - S359 - Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model(2020)
Authors: Ilhan Inci, Stephan Arni, Ilker Iskender, Necati Citak, Josep Monne Rodriguez, Miriam Weisskopf, Isabelle Opitz, Walter Weder, Thomas Frauenfelder, Marie Pierre Krafft, et al.
- Remediastinoscopy: a dangerous tool?(2008)
Authors: Paul De Leyn, Toni Lerut
Pages: 708 - 709 - Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial(2014)
Authors: Thierry Troosters, Frank C Sciurba, Marc Decramer, Nikos M Siafakas, Solomon S Klioze, Santosh C Sutradhar, Idelle M Weisman, Carla Yunis
Pages: 1 - 8 - Computed Tomography Characteristics Predictive for Radial EBUS-Miniprobe-Guided Diagnosis of Pulmonary Lesions(2015)
Authors: Canan Guvenc, Jonas Yserbyt, Dries Testelmans, Federica Zanca, An Carbonez, Vincent Ninane, Walter De Wever, Christophe Dooms
Pages: 472 - 8